Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1972 1
1973 1
1974 4
1975 4
1976 7
1977 5
1978 8
1979 4
1980 5
1981 5
1982 8
1983 11
1984 10
1985 18
1986 13
1987 23
1988 20
1989 19
1990 32
1991 28
1992 38
1993 49
1994 58
1995 49
1996 61
1997 70
1998 67
1999 68
2000 64
2001 64
2002 55
2003 73
2004 81
2005 97
2006 95
2007 121
2008 123
2009 108
2010 96
2011 125
2012 136
2013 164
2014 149
2015 149
2016 161
2017 132
2018 134
2019 137
2020 127
2021 134
2022 116
2023 102
2024 32

Text availability

Article attribute

Article type

Publication date

Search Results

3,103 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Benign male reproductive system neoplasm"
Page 1
Prostate Cancer in Primary Care.
Merriel SWD, Funston G, Hamilton W. Merriel SWD, et al. Adv Ther. 2018 Sep;35(9):1285-1294. doi: 10.1007/s12325-018-0766-1. Epub 2018 Aug 10. Adv Ther. 2018. PMID: 30097885 Free PMC article. Review.
However, there is significant crossover in symptoms between prostate cancer and benign conditions affecting the prostate such as benign prostatic hypertrophy (BPH) and prostatitis, making it very challenging to distinguish between them on the basis of symptoms. ...D …
However, there is significant crossover in symptoms between prostate cancer and benign conditions affecting the prostate such as b …
Risk Factors and Treatment Outcomes of 1,375 Patients with Testicular Leydig Cell Tumors: Analysis of Published Case Series Data.
Fankhauser CD, Grogg JB, Hayoz S, Wettstein MS, Dieckmann KP, Sulser T, Bode PK, Clarke NW, Beyer J, Hermanns T. Fankhauser CD, et al. J Urol. 2020 May;203(5):949-956. doi: 10.1097/JU.0000000000000705. Epub 2019 Dec 17. J Urol. 2020. PMID: 31845841 Free article. Review.
Only limited evidence exists for reliably differentiating between benign and malignant Leydig cell tumors and for optimally managing the different types and stages of this rare disease. ...The multivariable models with or without multiple imputation predicting metas …
Only limited evidence exists for reliably differentiating between benign and malignant Leydig cell tumors and for optimally managing …
Paratesticular mesothelial proliferations.
Churg A. Churg A. Semin Diagn Pathol. 2003 Nov;20(4):272-8. doi: 10.1053/j.semdp.2003.08.003. Semin Diagn Pathol. 2003. PMID: 14694980 Review.
The proliferating mesothelial cells in benign reactions often form lines that are parallel to the surface of the hydrocoele. ...Well-differentiated papillary mesotheliomas are usually solitary exophytic nodules with a distinctive morphologic appearance and benign …
The proliferating mesothelial cells in benign reactions often form lines that are parallel to the surface of the hydrocoele. ...Well- …
Artificial Intelligence and Pathomics: Prostate Cancer.
Azadi Moghadam P, Bashashati A, Goldenberg SL. Azadi Moghadam P, et al. Urol Clin North Am. 2024 Feb;51(1):15-26. doi: 10.1016/j.ucl.2023.06.001. Epub 2023 Jul 25. Urol Clin North Am. 2024. PMID: 37945099 Review.
Artificial intelligence (AI) has the potential to transform pathologic diagnosis and cancer patient management as a predictive and prognostic biomarker. AI-based systems can be used to examine digitally scanned histopathology slides and differentiate benign f …
Artificial intelligence (AI) has the potential to transform pathologic diagnosis and cancer patient management as a predictive and …
Comparative Expression of RAGE and SOX2 in Benign and Malignant Prostatic Lesions.
Aboushousha T, Lashen R, Abdelnaser K, Helal N, Moussa M, Omran Z, Eldahshan S, El Ganzoury H. Aboushousha T, et al. Asian Pac J Cancer Prev. 2019 Feb 26;20(2):615-620. doi: 10.31557/APJCP.2019.20.2.615. Asian Pac J Cancer Prev. 2019. PMID: 30806068 Free PMC article.
Aim: The current study investigated the expression patterns of RAGE and SOX2 in benign and malignant prostate samples in correlation with the histopathological findings in order to evaluate their role as prognostic markers or therapeutic targets. Methods: Immunohist …
Aim: The current study investigated the expression patterns of RAGE and SOX2 in benign and malignant prostate samples in correlation …
New and Emerging Diagnostic and Prognostic Immunohistochemical Biomarkers in Prostate Pathology.
Giannico GA, Arnold SA, Gellert LL, Hameed O. Giannico GA, et al. Adv Anat Pathol. 2017 Jan;24(1):35-44. doi: 10.1097/PAP.0000000000000136. Adv Anat Pathol. 2017. PMID: 27941540 Free PMC article. Review.
However, there are caveats associated with the interpretation of these markers, particularly with benign mimickers. Another issue is that of early detection of presence and progression of disease and prediction of recurrence after clinical intervention. ...New bioma …
However, there are caveats associated with the interpretation of these markers, particularly with benign mimickers. Another issue is …
Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases.
Herbster S, Paladino A, de Freitas S, Boccardo E. Herbster S, et al. Clinics (Sao Paulo). 2018 Sep 6;73(suppl 1):e551s. doi: 10.6061/clinics/2018/e551s. Clinics (Sao Paulo). 2018. PMID: 30208169 Free PMC article. Review.
Infection with human papillomaviruses is associated with a series of benign and malignant hyperproliferative diseases that impose a heavy burden on human populations. ...Matrix metalloproteinases function by remodeling the extracellular matrix and alterations in their expr …
Infection with human papillomaviruses is associated with a series of benign and malignant hyperproliferative diseases that impose a h …
The link between benign prostatic hyperplasia and prostate cancer.
Ørsted DD, Bojesen SE. Ørsted DD, et al. Nat Rev Urol. 2013 Jan;10(1):49-54. doi: 10.1038/nrurol.2012.192. Epub 2012 Nov 20. Nat Rev Urol. 2013. PMID: 23165396 Review.
Benign prostatic hyperplasia (BPH) and prostate cancer are among the most common diseases of the prostate gland and represent significant burdens for patients and health-care systems in many countries. ...Establishing BPH as a causal factor for prostate cancer development …
Benign prostatic hyperplasia (BPH) and prostate cancer are among the most common diseases of the prostate gland and represent signifi …
The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer.
Ma C, Zhou Y, Fanelli GN, Stopsack KH, Fiorentino M, Zadra G, Mucci LA, Loda M, Tyekucheva S, Penney KL. Ma C, et al. Mol Cancer Res. 2023 Mar 1;21(3):253-260. doi: 10.1158/1541-7786.MCR-22-0627. Mol Cancer Res. 2023. PMID: 36511902 Free PMC article.

Prostate cancer has a heterogeneous prognosis. Most previous studies have focused on the identification of prognostic biomarkers in the prostate cancer tumor. ...Comparing high- with low-Gleason score cancers, 26 genes (P < 0.001) and 12 pathways (FDR < 0.20)

…
Prostate cancer has a heterogeneous prognosis. Most previous studies have focused on the identification of prognostic biomarke …
Low Gleason score prostatic adenocarcinomas are no longer viable entities.
Berney DM. Berney DM. Histopathology. 2007 May;50(6):683-90. doi: 10.1111/j.1365-2559.2007.02596.x. Histopathology. 2007. PMID: 17493232 Review.
Gleason scoring is the most powerful predictor of the behaviour of prostatic adenocarcinoma. It was devised more than 30 years ago and is used by pathologists worldwide. ...It is suggested that Gleason score 2(1 + 1) tumours, if they do exist, are so rare and so benign …
Gleason scoring is the most powerful predictor of the behaviour of prostatic adenocarcinoma. It was devised more than 30 years ago an …
3,103 results